216 related articles for article (PubMed ID: 22962024)
1. A structured approach to choosing estimands and estimators in longitudinal clinical trials.
Mallinckrodt CH; Lin Q; Lipkovich I; Molenberghs G
Pharm Stat; 2012; 11(6):456-61. PubMed ID: 22962024
[TBL] [Abstract][Full Text] [Related]
2. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
Mallinckrodt CH; Lin Q; Molenberghs M
Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
[TBL] [Abstract][Full Text] [Related]
3. Choosing estimands in clinical trials with missing data.
Mallinckrodt C; Molenberghs G; Rathmann S
Pharm Stat; 2017 Jan; 16(1):29-36. PubMed ID: 27492760
[TBL] [Abstract][Full Text] [Related]
4. A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trials.
Ayele BT; Lipkovich I; Molenberghs G; Mallinckrodt CH
J Biopharm Stat; 2014; 24(2):211-28. PubMed ID: 24605966
[TBL] [Abstract][Full Text] [Related]
5. Missing data sensitivity analysis for recurrent event data using controlled imputation.
Keene ON; Roger JH; Hartley BF; Kenward MG
Pharm Stat; 2014; 13(4):258-64. PubMed ID: 24931317
[TBL] [Abstract][Full Text] [Related]
6. A local influence sensitivity analysis for incomplete longitudinal depression data.
Shen S; Beunckens C; Mallinckrodt C; Molenberghs G
J Biopharm Stat; 2006 May; 16(3):365-84. PubMed ID: 16724491
[TBL] [Abstract][Full Text] [Related]
7. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
[TBL] [Abstract][Full Text] [Related]
8. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation.
Carpenter JR; Roger JH; Kenward MG
J Biopharm Stat; 2013; 23(6):1352-71. PubMed ID: 24138436
[TBL] [Abstract][Full Text] [Related]
9. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
Siddiqui O
J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
[TBL] [Abstract][Full Text] [Related]
10. Estimands: discussion points from the PSI estimands and sensitivity expert group.
Phillips A; Abellan-Andres J; Soren A; Bretz F; Fletcher C; France L; Garrett A; Harris R; Kjaer M; Keene O; Morgan D; O'Kelly M; Roger J
Pharm Stat; 2017 Jan; 16(1):6-11. PubMed ID: 26997517
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
[TBL] [Abstract][Full Text] [Related]
12. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
13. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
14. Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatment.
Roger JH; Bratton DJ; Mayer B; Abellan JJ; Keene ON
Pharm Stat; 2019 Jan; 18(1):85-95. PubMed ID: 30406948
[TBL] [Abstract][Full Text] [Related]
15. Imputation of missing variance data using non-linear mixed effects modelling to enable an inverse variance weighted meta-analysis of summary-level longitudinal data: a case study.
Boucher M
Pharm Stat; 2012; 11(4):318-24. PubMed ID: 22566382
[TBL] [Abstract][Full Text] [Related]
16. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
[TBL] [Abstract][Full Text] [Related]
17. An analytic method for the placebo-based pattern-mixture model.
Lu K
Stat Med; 2014 Mar; 33(7):1134-45. PubMed ID: 24122822
[TBL] [Abstract][Full Text] [Related]
18. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction.
Keene ON
Pharm Stat; 2019 Jan; 18(1):78-84. PubMed ID: 30370691
[TBL] [Abstract][Full Text] [Related]
19. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations.
Mallinckrodt CH; Clark SW; Carroll RJ; Molenbergh G
J Biopharm Stat; 2003 May; 13(2):179-90. PubMed ID: 12729388
[TBL] [Abstract][Full Text] [Related]
20. Handling of missing data in long-term clinical trials: a case study.
Janssens M; Molenberghs G; Kerstens R
Pharm Stat; 2012; 11(6):442-8. PubMed ID: 22888095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
